StonvexLoading…
StonvexStonvexStonvexCore line items from BDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $21.84B | $20.18B | $19.37B | $18.87B |
Operating Income | $2.58B | $2.40B | $2.11B | $2.28B |
Net Income | $1.68B | $1.71B | $1.48B | $1.78B |
EPS (Diluted) | $5.82 | $5.86 | $4.94 | $5.88 |
Total Assets | $55.33B | $57.29B | $52.78B | $52.93B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $641.00M | $1.72B | $1.42B | $1.01B |
Free Cash Flow OCF − CapEx | $2.67B | $3.12B | $2.12B | $1.50B |
Shares Outstanding | 288.51M | 291.01M | 288.39M | 287.36M |